Vitamin E for Nonalcoholic Fatty Liver Disease

Abstract

Get full access to this article

View all access options for this article.

References

Poddar

Kolge

Bezman

Mullin

Cheskin

. Nutraceutical Supplements for Weight Loss: A Systematic Review. Nutr Clin Pract. 2011;26:539-552.

Vernon

Baranova

Younossi

. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274-285.

Meydani

. Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol. 2008;84(4):900-914.

Nan

. Antioxidants vitamin E and 1- aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Scand J Gastroenterol. 2009;44(9):1121-1131.

Sanyal

Mofrad

Contos

. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2004;2(12):1107-1115.

Lavine

. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr. 2000;136(6):734-738.

Harrison

Torgerson

Hayashi

Ward

Schenker

. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2003;98(11):2485-2490.

Sanyal

Chalasani

Kowdley

. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675-1685.